The Base of COMBACTE's Future

Read more
combacte News Item

Is There Life After COMBACTE?

Much is being invested in the establishment of CLIN-Net and LAB-Net. Wouldn’t it be a shame if European society ceases to benefit from this after 2021? The answer is obvious. This story is about looking at the future and a fruitful cooperation. Prof. Dr. Marc Bonten (Scientific Coordinator COMBACTE) and Prof. Herman Goossens (Academic Lead COMBACTE-NET and LAB-Net, and Coordinator for PREPARE) share their views on the future existence of an active European network for clinical trials in infectious diseases: ECRAID.

ECRAID Piece

 

12/01/2021

Tocilizumab and Sarilumab effective in improving survival in sickest COVID-19 patients

07/01/2021

Finding Innovative Solutions for Tackling Infectious Diseases

04/01/2021

RECOVER Continues Enrollment And Adds New Work Package